These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32333801)

  • 21. Independent and concomitant associations of gestational diabetes and maternal obesity to perinatal outcome: A register-based study.
    Ijäs H; Koivunen S; Raudaskoski T; Kajantie E; Gissler M; Vääräsmäki M
    PLoS One; 2019; 14(8):e0221549. PubMed ID: 31465425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
    Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
    Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prospective association of hyperandrogenism, oligomenorrhea and polycystic ovary syndrome with incident gestational diabetes: The coronary artery risk development in young adults women's study.
    Appiah D; Hedderson MM; Kim C; Sidney S; Sternfeld B; Quesenberry CP; Wellons MF; Gunderson EP
    Diabetes Res Clin Pract; 2023 Apr; 198():110593. PubMed ID: 36868515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of maternal obesity and gestational diabetes mellitus with overweight/obesity and fatty liver risk in offspring.
    Zeng J; Shen F; Zou ZY; Yang RX; Jin Q; Yang J; Chen GY; Fan JG
    World J Gastroenterol; 2022 Apr; 28(16):1681-1691. PubMed ID: 35581961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study.
    Zheng W; Huang W; Zhang L; Tian Z; Yan Q; Wang T; Zhang L; Li G
    Diabetol Metab Syndr; 2019; 11():71. PubMed ID: 31462934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome and risk factors for gestational diabetes.
    Mustaniemi S; Vääräsmäki M; Eriksson JG; Gissler M; Laivuori H; Ijäs H; Bloigu A; Kajantie E; Morin-Papunen L
    Endocr Connect; 2018 Jul; 7(7):859-869. PubMed ID: 29858213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
    de Wilde MA; Veltman-Verhulst SM; Goverde AJ; Lambalk CB; Laven JS; Franx A; Koster MP; Eijkemans MJ; Fauser BC
    Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.
    Holte J; Gennarelli G; Wide L; Lithell H; Berne C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1143-50. PubMed ID: 9543131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.
    Sung YA; Oh JY; Chung H; Lee H
    Fertil Steril; 2014 Mar; 101(3):840-5. PubMed ID: 24424368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-pregnancy overweight or obesity and gestational diabetes as predictors of body composition in offspring twenty years later: evidence from two birth cohort studies.
    Kaseva N; Vääräsmäki M; Matinolli HM; Sipola-Leppänen M; Tikanmäki M; Heinonen K; Lano A; Wolke D; Andersson S; Järvelin MR; Räikkönen K; Eriksson JG; Kajantie E
    Int J Obes (Lond); 2018 Apr; 42(4):872-879. PubMed ID: 29146992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.
    Jones H; Sprung VS; Pugh CJ; Daousi C; Irwin A; Aziz N; Adams VL; Thomas EL; Bell JD; Kemp GJ; Cuthbertson DJ
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3709-16. PubMed ID: 22837189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of maternal obesity in infant outcomes in polycystic ovary syndrome-A systematic review, meta-analysis, and meta-regression.
    Bahri Khomami M; Joham AE; Boyle JA; Piltonen T; Arora C; Silagy M; Misso ML; Teede HJ; Moran LJ
    Obes Rev; 2019 Jun; 20(6):842-858. PubMed ID: 30785659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of polycystic ovary syndrome and related disorders in mexican women.
    Moran C; Tena G; Moran S; Ruiz P; Reyna R; Duque X
    Gynecol Obstet Invest; 2010; 69(4):274-280. PubMed ID: 20110726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pregnancy complications among women with polycystic ovary syndrome in China: a Meta-analysis].
    Wang T; Fu H; Chen L; Xu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1300-1310. PubMed ID: 29187658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal gestational diabetes, birth weight, and adolescent obesity.
    Gillman MW; Rifas-Shiman S; Berkey CS; Field AE; Colditz GA
    Pediatrics; 2003 Mar; 111(3):e221-6. PubMed ID: 12612275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and late pregnancy loss in women with polycystic ovary syndrome undergoing IVF/ICSI treatment: a retrospective cohort analysis of 21 820 pregnancies.
    Cai H; Mol BW; Gordts S; Wang H; Wang T; Li N; Shi J
    BJOG; 2021 Jun; 128(7):1160-1169. PubMed ID: 33142019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High pre-pregnancy BMI with a history of gestational diabetes mellitus is associated with an increased risk of type 2 diabetes in Korean women.
    Shin D; Lee KW
    PLoS One; 2021; 16(6):e0252442. PubMed ID: 34086709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population.
    Salva-Pastor N; López-Sánchez GN; Chávez-Tapia NC; Audifred-Salomón JR; Niebla-Cárdenas D; Topete-Estrada R; Pereznuñez-Zamora H; Vidaltamayo-Ramírez R; Báez-Arellano ME; Uribe M; Nuño-Lámbarri N
    Ann Hepatol; 2020; 19(3):251-257. PubMed ID: 32111488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.